These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 2691131

  • 1. Value of angiotensin converting enzyme inhibitors in the elderly: the example of perindopril.
    Forette F, McClaran J, Delesalle MC, Hervy MP, Bouchacourt P, Henry-Amar M, Santoni JP.
    Clin Exp Hypertens A; 1989; 11 Suppl 2():587-603. PubMed ID: 2691131
    [Abstract] [Full Text] [Related]

  • 2. [Significance of inhibitors of conversion enzymes in elderly subjects. The example of perindopril].
    Forette F, McClaran JM, Delesalle MC, Hervy MP, Bouchacourt P, Henry-Amar M, Santoni JP.
    Arch Mal Coeur Vaiss; 1989 May; 82 Spec No 1():79-85. PubMed ID: 2505717
    [Abstract] [Full Text] [Related]

  • 3. Value of perindopril in the treatment of chronic congestive heart failure. Multicenter double-blind placebo-controlled study.
    Bounhoure JP, Bottineau G, Lechat P, Garnham J, Lapeyre G.
    Clin Exp Hypertens A; 1989 May; 11 Suppl 2():575-86. PubMed ID: 2691130
    [Abstract] [Full Text] [Related]

  • 4. A double blind comparison of perindopril and atenolol in essential hypertension.
    Thurston H, Mimran A, Zanchetti A, Creytens G, Rorive G, Brown CL, Santoni JP.
    J Hum Hypertens; 1990 Oct; 4(5):547-52. PubMed ID: 2283644
    [Abstract] [Full Text] [Related]

  • 5. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
    Mallion JM, Chamontin B, Asmar R, De Leeuw PW, O'Brien E, Duprez D, O'Rourke MF, Rahn KH, Romero R, Battegay E, Hitzenberger G, Safar ME, REASON Project.
    Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
    [Abstract] [Full Text] [Related]

  • 6. Therapeutic safety of perindopril in the treatment of mild hypertension with concomitant nephropathy.
    Bönner G, Lederle RM, Scholze J, Stumpe KO.
    Arzneimittelforschung; 1993 Aug; 43(8):852-5. PubMed ID: 8216441
    [Abstract] [Full Text] [Related]

  • 7. PROGRESS--perindopril protection against recurrent stroke study: status in July 1996. PROGRESS Management Committee.
    J Hypertens Suppl; 1996 Dec; 14(6):S47-51. PubMed ID: 9023716
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of perindopril on elastic and structural properties of large arteries in essential hypertension.
    Lacourcière Y, Béliveau R, Conter HS, Burgess ED, Lepage S, Pesant Y, Spence JD, Asmar R, Carrière S, Plante GE, Canadian Hypertension Society.
    Can J Cardiol; 2004 Jun; 20(8):795-9. PubMed ID: 15229761
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of angiotensin-converting enzyme inhibition with perindopril on left ventricular remodeling and clinical outcome: results of the randomized Perindopril and Remodeling in Elderly with Acute Myocardial Infarction (PREAMI) Study.
    Ferrari R, Perindopril and Remodeling in Elderly with Acute Myocardial Infarction Investigators.
    Arch Intern Med; 2006 Mar 27; 166(6):659-66. PubMed ID: 16567606
    [Abstract] [Full Text] [Related]

  • 14. [Cardiac hypertrophy and arterial compliance after antihypertensive treatment].
    Asmar RG, Pannier BM, London GM, Safar ME.
    Arch Mal Coeur Vaiss; 1991 Dec 27; 84 Spec No 4():79-83. PubMed ID: 1838923
    [Abstract] [Full Text] [Related]

  • 15. [Long-term decrease of microalbuminuria after one year of treatment with perindopril in hypertensive diabetic patients].
    Brichard SM, Santoni JP, Thomas JR, Van de Voorde K, Ketelslegers JM, Lambert AE.
    Ann Cardiol Angeiol (Paris); 1990 Oct 27; 39(8):495-9. PubMed ID: 2281920
    [Abstract] [Full Text] [Related]

  • 16. Angiotensin converting enzyme inhibition, pulse wave velocity and ambulatory blood pressure measurements in essential hypertension.
    Santoni JP, Asmar R, Safar ME.
    Clin Exp Hypertens A; 1989 Oct 27; 11 Suppl 2():535-44. PubMed ID: 2691127
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Angiotensin converting enzyme inhibition decreases systolic blood pressure more than diastolic pressure as shown by ambulatory blood pressure monitoring.
    Asmar RG, Pannier BM, Santoni JP, Safar ME.
    J Hypertens Suppl; 1988 Dec 27; 6(3):S79-81. PubMed ID: 3225692
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.